These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8900258)

  • 1. British ruling supports legal challenge to broad patents.
    Dickson D
    Nature; 1996 Nov; 384(6604):7. PubMed ID: 8900258
    [No Abstract]   [Full Text] [Related]  

  • 2. Affymetrix license valid, rules court.
    Robertson D
    Nat Biotechnol; 2001 Jan; 19(1):13-4. PubMed ID: 11135539
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotechnology patents under fire.
    Royzman I
    Nat Biotechnol; 2015 Sep; 33(9):925-6. PubMed ID: 26348959
    [No Abstract]   [Full Text] [Related]  

  • 4. Patents, biotechnology, and hematologic pathology.
    Kettelberger DM; Gambrell P; McClung G
    Hematol Pathol; 1992; 6(2):99-104. PubMed ID: 1607346
    [No Abstract]   [Full Text] [Related]  

  • 5. European Commission rethinks biotech patents.
    Mitchell P
    Nat Biotechnol; 2002 Dec; 20(12):1175-6. PubMed ID: 12454654
    [No Abstract]   [Full Text] [Related]  

  • 6. US court case to define EST patentability.
    Lawrence S
    Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055
    [No Abstract]   [Full Text] [Related]  

  • 7. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 8. Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive.
    Van Overwalle G
    Rev Derecho Genoma Hum; 2003; (19):187-203. PubMed ID: 15032104
    [No Abstract]   [Full Text] [Related]  

  • 9. The morality of biotech patents: differing legal obligations in Europe?
    Ford R
    Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 11. Patenting the parts.
    Nat Biotechnol; 2007 Aug; 25(8):822. PubMed ID: 17687343
    [No Abstract]   [Full Text] [Related]  

  • 12. Patenting pieces of people.
    Nat Biotechnol; 2003 Apr; 21(4):341. PubMed ID: 12665804
    [No Abstract]   [Full Text] [Related]  

  • 13. Patenting pluripotence: the next battle for stem cell intellectual property.
    Vrtovec KT; Scott CT
    Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harvard mouse--eating into the European patent system?
    Wickremasinghe K
    Australas Biotechnol; 1992 Feb; 2(1):44-6. PubMed ID: 1368031
    [No Abstract]   [Full Text] [Related]  

  • 15. The prodigal son: the relationship between patent law and health care.
    Bostyn SJ
    Med Law Rev; 2003; 11(1):67-120. PubMed ID: 14606473
    [No Abstract]   [Full Text] [Related]  

  • 16. European Directive on the Legal Protection of Biotechnological Inventions: scope, status and controversies in a nutshell.
    Hakki MM
    E Law; 2004 Mar; 11(1):E4. PubMed ID: 16903025
    [No Abstract]   [Full Text] [Related]  

  • 17. Should there be property rights in genes?
    Dworkin G
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1077-86. PubMed ID: 9304674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More patent troubles about genes.
    Nature; 1994 Dec; 372(6506):485. PubMed ID: 7990908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioartificiality thresholds: oscillations of genetic patenting].
    Tallacchini M
    Rev Derecho Genoma Hum; 2003; (18):115-36. PubMed ID: 14562472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of patent interferences in gene technology.
    Merz JF; Henry MR
    Nat Biotechnol; 2004 Feb; 22(2):153-4. PubMed ID: 14755283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.